BENGALURU: Biocon Foundation has unveiled a breathtaking public art spectacle, turning over 50 Metro pillars between Huskur ...

The University of Glasgow has launched an innovative and exciting new postgraduate study programme with Indian biopharmaceutical giant Biocon.

The "Adalimumab, Infliximab, Etanercept and Trastuzumab Biosimilars Market Opportunities and Strategies to 2033" report has ...

Bengaluru: The Electronics City Metro corridor, between Huskur Gate and Hebbagodi, has got a colourful facelift with 43 ...

Biocon Foundation transforms metro pillars into art celebrating Bengaluru's unsung heroes, merging heritage with urban landscape.

Equillium (EQ) and Biocon announced topline results from the Phase 2 study evaluating itolizumab in the treatment of moderate to severe ...

Peter Bains, Group CEO of Biocon, discusses his outlook and strategy for business growth after the company's latest earnings, ...

Peter Bains, Group CEO of Biocon, talks about India's budget, and the impact of its plans to cut or remove duties on ...

HYDERABAD -Indian biopharmaceutical firm Biocon is likely to list its key biosimilars business by March 2026 and aims for a double-digit share in its core U.S. market for its new launches ...